<DOC>
	<DOC>NCT00540059</DOC>
	<brief_summary>Purpose of this study is the evaluation of QoL, tolerability and use of Zoladex 10,8 SafeSystem for advanced PCa under naturalistic conditions</brief_summary>
	<brief_title>Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP Trial</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<criteria>Patients with PCa, who will be treated with Zoladex 10,8 SafeSystem based on the current SPC</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Prostate carcinoma</keyword>
	<keyword>LHRH</keyword>
	<keyword>Zoladex</keyword>
</DOC>